RemSleep Holdings (RMSL) EBT Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | RemSleep Holdings | - | - | -7,636.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.93% |
| Sep 30, 2025 | -53.48% |
| Jun 30, 2025 | -56.58% |
| Mar 31, 2025 | 20.75% |
| Dec 31, 2024 | 18.09% |
| Sep 30, 2024 | -29.22% |
| Jun 30, 2024 | 37.40% |
| Mar 31, 2024 | 15.66% |
| Dec 31, 2023 | -35.73% |
| Sep 30, 2023 | 4.97% |
| Jun 30, 2023 | 6.21% |
| Mar 31, 2023 | -6.89% |
| Dec 31, 2022 | -37.27% |
| Sep 30, 2022 | -23.19% |
| Jun 30, 2022 | -9.04% |
| Mar 31, 2022 | -12.88% |
| Dec 31, 2021 | 1.39% |
| Sep 30, 2021 | -410.08% |
| Jun 30, 2021 | -274.01% |
| Mar 31, 2021 | -78.17% |
| Dec 31, 2020 | -118.73% |
| Sep 30, 2020 | -311.53% |
| Jun 30, 2020 | 24.62% |
| Mar 31, 2020 | -51.60% |
| Dec 31, 2019 | -32.66% |
| Sep 30, 2019 | -40.70% |
| Jun 30, 2019 | -156.76% |
| Mar 31, 2019 | -96.95% |
| Dec 31, 2018 | 31.20% |
| Sep 30, 2018 | -14.05% |
| Jun 30, 2018 | 17.24% |
| Mar 31, 2018 | 4.70% |
| Dec 31, 2017 | 20.01% |
| Sep 30, 2017 | 25.22% |
| Jun 30, 2017 | 15.27% |
| Mar 31, 2017 | -58.50% |
| Dec 31, 2016 | -49.60% |
| Jun 30, 2016 | 45.82% |
| Mar 31, 2016 | -6.62% |
| Dec 31, 2015 | 83.61% |
| Sep 30, 2015 | 76.65% |